Walgreens Closes 1,200 Stores as CVS Captures Suburban Pharmacy Market

Corporate ActionIndustryEarnings
โดย TheStreet·US·Read original
Summary · why it matters

Walgreens is closing roughly 1,200 of its approximately 8,500 U.S. locations through 2027, a retreat that is quietly handing suburban pharmacy customers to CVS. The closures accelerated after Walgreens completed a $10 billion sale to private equity firm Sycamore Partners in August 2025, taking the 124-year-old chain private for the first time; Mike Motz was named chief executive, replacing Tim Wentworth, who stays on as a director, and John Lederer became executive chairman. Company leadership has blamed shrinking pharmacy reimbursement rates, weaker retail traffic, and competition from Amazon Pharmacy for the decision, saying roughly a quarter of stores no longer fit the chain's strategy. CVS, which owns the pharmacy benefit manager Caremark, has not needed a marketing campaign to gain ground, and CVS and Walgreens together now handle nearly 40% of all U.S. retail prescription sales. CVS posted more than $106 billion in revenue and adjusted operating income of roughly $5.2 billion in its second-quarter 2026 results, up more than 35% from a year earlier, and raised its full-year 2026 adjusted earnings per share guidance to a range of $7.90 to $8.10. Walgreens has committed to continuing closures through 2027, with roughly 100 more expected before the end of 2026, while CVS is opening small-format stores, folding in leftover Rite Aid real estate, and leaning into GLP-1 access through new partnerships with Eli Lilly and Novo Nordisk.

Impact on stocks 5

Health Care▲ · 2 stocks
CVS Health Corp
CVS
▲ PositiveDemandCapitalrelevance

Walgreens' 1,200 store closures are handing suburban pharmacy customers to CVS, which is gaining share without marketing and opening small-format stores.

Biotech & Genomic Medicine▲ · 2 stocks
Eli Lilly and Company
LLY
▲ PositiveDemandrelevance

CVS is leaning into GLP-1 access through new partnerships with Eli Lilly, a potential demand channel for Lilly's products.

Novo Nordisk A/S
NOV
▲ PositiveDemandrelevance

CVS is leaning into GLP-1 access through new partnerships with Novo Nordisk, a potential demand channel for Novo's products.

Artificial Intelligence▲ · 1 stocks

Off-coverage companies 2

Walgreens Boots AlliancePrivate▼ Negative
Competitionrelevance

Walgreens is closing ~1,200 stores through 2027 as CVS captures suburban pharmacy customers, with leadership blaming reimbursement, weak traffic, and Amazon Pharmacy competition.

Sycamore PartnersPrivate± Mixed
relevance

© 2026 MarketDXNews